SOBI
SOBI is a Sweden-based biopharmaceutical company that develops and commercializes therapies for the treatment of hemophilia and cancer.
Business Model:
Revenue: $1.8B
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed SOBI Information
Geographic Data
Address: Tomtebodavagen 23A
City: Solna
State: stockholms län
Zip: 112 76
Country: SE
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
1,371,340Website Global Rank
19,981Website Monthly Traffic
Twitter Followers
Description
SOBI is a Sweden-based biopharmaceutical company that develops and commercializes therapies for the treatment of hemophilia and cancer.
Contact Phone:
Contact Email:
SOBI went public on 9/15/2006 on the Nasdaq OMX Nordic
Listed Exchange:
Nasdaq OMX Nordic
IPO Date:
9/15/2006
Ticker Symbol:
SOBI
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 5/2023 | CTI BioPharma | |
| 9/2019 | Dova Pharmaceuticals | |
| 11/2009 | Biovitrum | |
| 10/2007 | Swedish Orphan International Manufacturing |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
